AbbVie Inc. (NYSE: ABBV ) looks like an apparent 'Strong Buy' not only because of the 17% upside potential derived by my DCF model. The business is fundamentally strong with a solid diversified business mix, which is protected by long-term patents forComing from an IT background, I have dived into the U.S. stock market seven years ago by managing portfolio of my family. Starting managing real money has been challenging for the first time, but long hours of mastering fundamental analysis of public companies ...